Employees Retirement System of Texas’s ADC Therapeutics ADCT Stock Holding History

Employees Retirement System of Texas’s Portfolio ADCT Stock Details ADCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-56,227	Closed	-$271K	–	336
2022 Q3	$271K	Sell	56,227 -255,773	-82%	-$1.85M	﹤0.01%	327
2022 Q2	$2.48M	Hold	312,000	–	–	0.04%	442
2022 Q1	$4.58M	Buy	312,000 +34,000	+12%	+$540K	0.05%	342
2021 Q4	$5.62M	Buy	278,000 +48,000	+21%	+$1.16M	0.06%	309
2021 Q3	$6.25M	Buy	230,000 +36,000	+19%	+$922K	0.07%	292
2021 Q2	$4.72M	Buy	194,000 +59,000	+44%	+$1.37M	0.06%	344
2021 Q1	$3.29M	Buy	+135,000	New	+$3.91M	0.04%	436

Other funds holding ADCT

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Employees Retirement System of Texas's ADCT Position: Q4 2022 in Review

Employees Retirement System of Texas sold out of ADC Therapeutics (ADCT) in Q4 2022, closing a stake of 56,227 shares — an estimated $271K sold.

Employees Retirement System of Texas first reported a position in ADCT in Q1 2021 and held it in 7 quarters. The position peaked at $6.25M in Q3 2021. 60 funds tracked by Wall St. Rank hold ADCT as of Q4 2022.

Employees Retirement System of Texas reported no remaining ADC Therapeutics position as of Q4 2022 after selling out during the quarter.
Employees Retirement System of Texas sold 56,227 ADC Therapeutics shares in Q4 2022, an estimated $271K.
Employees Retirement System of Texas first reported a position in ADC Therapeutics in Q1 2021 and held it in 7 quarters.
Employees Retirement System of Texas's ADC Therapeutics position peaked at $6.25M in Q3 2021.
60 funds tracked by Wall St. Rank held ADC Therapeutics as of Q4 2022.

Based on Employees Retirement System of Texas's 13F filing for Q4 2022, filed 15 Feb 2023.